Department of Neurosurgery, Copenhagen University Hospital, Inge Lehmanns Vej 6, 2100, Copenhagen, Denmark.
Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Acta Neurochir (Wien). 2022 Sep;164(9):2419-2430. doi: 10.1007/s00701-022-05303-w. Epub 2022 Jul 22.
The aim of the study was to investigate (1) the 30-day, 3-month, and 12-month cumulative mortalities for patients who underwent aneurysm occlusion, and (2) the causes of death, and (3) the potential risk factors for death.
All patients who underwent surgical clipping or endovascular treatment of a ruptured aneurysm at Copenhagen University Hospital, during the period of January 1, 2017-December 31, 2019, were included and followed up for 12 months. Data regarding vital status, causes of death, comorbidities, treatment, and clinical presentations on admission was collected. The absolute mortality risk was estimated as a function of time with a 95% confidence interval. The associations between potential risk factors and death were estimated as odds ratios with 95% confidence intervals using logistic regression models.
A total of 317 patients were included. The overall cumulative mortalities after 30 days, 3 months, and 12 months were 10.7%, 12.9%, and 16.1%, respectively. The most common cause of death was severe primary hemorrhage (52.9%), followed by infections (15.7%) and rebleeding (11.8%). WFNS score > 3 and Fisher score > 3 on admission, preprocedural hydrocephalus, and preprocedural rebleeding were found significantly associated with higher risk of death.
Considerable mortality was seen. Possible preventable causes accounted for approximately 22% of the deaths. The occurrence of both pre- and postprocedural rebleeding's indicates an opportunity of further improvement of the mortality by (1) further reduction of time from aSAH to aneurysm occlusion and (2) continuous efforts in improving methods of aneurysm occlusion.
本研究旨在:(1)调查接受动脉瘤闭塞治疗的患者在 30 天、3 个月和 12 个月的累计死亡率;(2)死亡原因;(3)潜在死亡风险因素。
本研究纳入了 2017 年 1 月 1 日至 2019 年 12 月 31 日期间在哥本哈根大学医院接受手术夹闭或血管内治疗破裂动脉瘤的所有患者,并对其进行了 12 个月的随访。收集了患者的生存状态、死亡原因、合并症、治疗和入院时的临床表现等数据。采用 95%置信区间估计绝对死亡风险随时间的函数。采用逻辑回归模型,以比值比及其 95%置信区间估计潜在风险因素与死亡之间的相关性。
共纳入 317 例患者。30 天、3 个月和 12 个月的总体累积死亡率分别为 10.7%、12.9%和 16.1%。最常见的死亡原因为严重原发性出血(52.9%),其次为感染(15.7%)和再出血(11.8%)。入院时 WFNS 评分>3 和 Fisher 评分>3、术前脑积水和术前再出血与死亡风险显著相关。
本研究中患者的死亡率较高,约 22%的死亡是可以预防的。再出血的发生无论是在术前还是术后,都表明通过(1)进一步缩短蛛网膜下腔出血至动脉瘤闭塞的时间,(2)持续努力改进动脉瘤闭塞方法,进一步降低死亡率的机会。